Single Biggest Cancer Dictionary in the World
What is ALK/c-Met inhibitor TQ-B3139?
Pronunciation: /alk* si mɛt ˌɪnˈhɪbətər tq* bi θri ˈθaʊzənd, wən ˈhənərd ənd thirty-nine*/
ALK/c-Met inhibitor TQ-B3139
Definition
An orally available, small molecule inhibitor of the receptor tyrosine kinases anaplastic lymphoma kinase (ALK) and hepatocyte growth factor receptor (c-Met; HGFR), with potential antineoplastic activity. Upon oral administration, TQ-B3139 binds to and inhibits the activity of ALK and c-Met, which leads to the disruption of ALK- and c-Met-mediated signaling and the inhibition of cell growth in ALK- and c-Met-expressing tumor cells. ALK and c-Met, overexpressed or mutated in many tumor cell types, play key roles in tumor cell proliferation, survival, invasion and metastasis.